ArticleInternational journal of molecular sciences2020

Cancer Immunotherapeutic Potential of NKTT320, a Novel, Invariant, Natural Killer T Cell-Activating, Humanized Monoclonal Antibody.

Nishant P Patel et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.